Eli Lilly and Company
PHARMACEUTICAL COMPOSITIONS
Last updated:
Abstract:
The present invention relates to solid oral fixed dose compositions of metformin, atorvastatin, and valsartan, or their pharmaceutically acceptable salts, processes for the preparation thereof, and the use of the composition to treat certain diseases.
Status:
Application
Type:
Utility
Filling date:
10 Jul 2018
Issue date:
13 May 2021